The goals of this continuation application are to identify important, and potentially novel amplified cancer-related genes in esophageal adenocarcinomas. This project involves the collaboration of investigators with substantial expertise in cancer and molecular genetics and focuses upon esophageal adenocarcinoma, a deadly cancer which is increasing in incidence. The identification of novel genomic amplifications, and the resulting important genes overexpressed in these tumors, will provide significant insight into the molecular events associated with the development and progression of this disease. This work may provide new genetic tools for early detection, and potentially for identifying new avenues for therapeutic intervention. We have identified a number of potentially novel genomic amplification events in esophageal adenocarcinomas using the highly sensitive method of quantitative two-dimensional genomic scanning (2D gels). This technology involves the comparative analysis of several thousand genomic restriction fragments derived from functional components of the genome between the normal and tumor tissue from an individual patient. The amplified and overexpressed genes encompassed in the amplicons will be identified and characterized, using the procedures we have successfully demonstrated for a novel amplicon in esophageal adenocarcinomas. 2D gels are particularly well suited for the identification of amplified regions of DNA. Amplified fragments will be cloned using procedures that we have successfully implemented and their chromosomal locations mapped using fluorescence in situ hybridization and/or database searches. Utilizing an innovative quantitative PCR assay and over 200 adenocarcinomas collected to date, the """"""""minimal region of common amplification"""""""" will be determined. This will effectively define the region to search for important amplified and overexpressed cancer-related genes. Potential candidates may include known genes, uncharacterized expressed sequence tags, or genes isolated from genomic clones that map within the minimal region. The cancer-relatedness of novel genes will be examined using functional assays involving transfection into immortalized cells and analysis of the effects upon cell growth, invasiveness, anchorage-independence and tumor formation in mice. These studies will determine both the identity and frequency of specific genes amplified in esophageal adenocarcinomas and also provide a greater insight into the mechanisms underlying the development and/or progression of this important cancer.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Project (R01)
Project #
Application #
Study Section
General Medicine A Subcommittee 2 (GMA)
Program Officer
Okano, Paul
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Michigan Ann Arbor
Schools of Medicine
Ann Arbor
United States
Zip Code
Wang, Zhuwen; Lin, Lin; Thomas, Dafydd G et al. (2015) The role of Dickkopf-3 overexpression in esophageal adenocarcinoma. J Thorac Cardiovasc Surg 150:377-385.e2
Lin, Lin; Bass, Adam J; Lockwood, William W et al. (2012) Activation of GATA binding protein 6 (GATA6) sustains oncogenic lineage-survival in esophageal adenocarcinoma. Proc Natl Acad Sci U S A 109:4251-6
Silvers, Amy L; Lin, Lin; Bass, Adam J et al. (2010) Decreased selenium-binding protein 1 in esophageal adenocarcinoma results from posttranscriptional and epigenetic regulation and affects chemosensitivity. Clin Cancer Res 16:2009-21
Boonstra, Jurjen J; van Marion, Ronald; Beer, David G et al. (2010) Verification and unmasking of widely used human esophageal adenocarcinoma cell lines. J Natl Cancer Inst 102:271-4
Bass, Adam J; Watanabe, Hideo; Mermel, Craig H et al. (2009) SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas. Nat Genet 41:1238-42
Jin, Zhe; Cheng, Yulan; Olaru, Alexandru et al. (2008) Promoter hypermethylation of CDH13 is a common, early event in human esophageal adenocarcinogenesis and correlates with clinical risk factors. Int J Cancer 123:2331-6
Zhao, Jia; Chang, Andrew C; Li, Chen et al. (2007) Comparative proteomics analysis of Barrett metaplasia and esophageal adenocarcinoma using two-dimensional liquid mass mapping. Mol Cell Proteomics 6:987-99
Lin, Lin; Wang, Zhuwen; Prescott, Michael S et al. (2006) Multiple forms of genetic instability within a 2-Mb chromosomal segment of 3q26.3-q27 are associated with development of esophageal adenocarcinoma. Genes Chromosomes Cancer 45:319-31
Miller, C T; Lin, L; Casper, A M et al. (2006) Genomic amplification of MET with boundaries within fragile site FRA7G and upregulation of MET pathways in esophageal adenocarcinoma. Oncogene 25:409-18
Lin, Jules; Raoof, Duna A; Wang, Zhuwen et al. (2006) Expression and effect of inhibition of the ubiquitin-conjugating enzyme E2C on esophageal adenocarcinoma. Neoplasia 8:1062-71

Showing the most recent 10 out of 25 publications